Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Precision medicine strategies for inflammatory bowel disease

ABSTRACT: Combining explainable machine learning, demographic and multi-omic data to identify precision medicine strategies for inflammatory bowel disease

PROVIDER: PRJEB43220 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Precision Medicine for Inherited Retinal Degenerations

Project description:Precision Medicine for Inherited Retinal Degenerations

| PRJNA736120 | ENA

Precision Medicine for Inherited Retinal Degenerations

Project description:Precision Medicine for Inherited Retinal Degenerations

| PRJNA736121 | ENA

The Brazilian Initiative on Precision Medicine (BIPMed)

Project description:The development of precision medicine strategies requires prior knowledge of the genetic background of the target population. However, despite the availability of data from admixed Americans within large reference population databases, we cannot use these data as a surrogate for that of the Brazilian population. This lack of transferability is mainly due to differences between ancestry proportions of Brazilian and other admixed American populations. To address the issue, a coalition of research centres created the Brazilian Initiative on Precision Medicine (BIPMed), an initiative of five Research Innovation and Dissemination Centers (RIDCs) supported by FAPESP.

2020-08-22 | GSE156652 | GEO

The Brazilian Initiative on Precision Medicine (BIPMed)

Project description:The Brazilian Initiative on Precision Medicine (BIPMed)

| PRJNA658602 | ENA

Precision medicine for ABCA4 disease: modifier alleles

Project description:Precision medicine for ABCA4 disease: modifier alleles

| PRJNA717338 | ENA

Precision medicine for ABCA4 disease: modifier alleles

Project description:Precision medicine for ABCA4 disease: modifier alleles

| PRJNA717339 | ENA

A single-cell based precision medicine approach using glioblastoma patient specific models

Project description:Glioblastoma (GBM) is a heterogeneous tumor made up of cell states that evolve over time. Here, we modeled tumor evolutionary trajectories during standard-of-care treatment using multi-omic single-cell analysis of a primary tumor sample, corresponding mouse xenografts subjected to standard of care therapy, and recurrent tumor at autopsy. We mined the multi-omic data with single cell SYstems Genetics Network AnaLysis (scSYGNAL) to identify a network of 52 regulators that mediate treatment-induced shifts in xenograft tumor-cell states that were also reflected in recurrence. By integrating scSYGNAL-derived regulatory network information with transcription factor accessibility deviations derived from single-cell ATAC-seq data, we developed consensus networks that modulate cell state transitions across subpopulations of primary and recurrent tumor cells. Finally, by matching targeted therapies to active regulatory networks underlying tumor evolutionary trajectories, we provide a framework for applying single-cell-based precision medicine approaches in a concurrent, adjuvant, or recurrent setting.

2022-07-01 | GSE189650 | GEO

Two circulating biomarkers are associated with the serological status of Rheumatoid Arthritis patients: a tool for precision medicine strategies

Project description:In the present work, we aimed to carry out a pipeline based on quantitative proteomics tools to discover, verify and validate circulating proteins that are associated with the presence in serum of RF and ACPA and may therefore have potential for the stratification of RA patients and the application of precision medicine strategies based on these molecular signatures.

2023-03-11 | PXD037386 | Pride

Functional precision medicine identifies new therapeutic candidates for medulloblastoma

Project description:Functional precision medicine identifies new therapeutic candidates for medulloblastoma

| PRJNA635569 | ENA

A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

Project description:A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia

| PRJNA422201 | ENA